(Q50156159)
Statements
Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial (English)
Federica Grosso
Nicola Steele
Silvia Novello
Laurent Greillier
Natasha B Leighl
Martin Reck
Paul Taylor
David Planchard
Jens Benn Sørensen
Mark A Socinski
Ute von Wangenheim
Arsène Bienvenu Loembé
José Barrueco
Nassim Morsli
Giorgio Scagliotti